Comparison between Nephro Care IPO and Petro Carbon IPO.
Nephro Care IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Petro Carbon IPO is a SME Bookbuilding proposed to list at NSE SME.
| Nephro Care IPO | Petro Carbon IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Corporate Capitalventures Pvt.Ltd. | GYR Capital Advisors Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | SS Corporate Securities Ltd. | Giriraj Stock Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Nephro Care IPO is up to ₹39.18 Cr whereas the issue size of the Petro Carbon IPO is up to ₹105.80 Cr. The final issue price of Nephro Care IPO is ₹90.00 per share and of Petro Carbon IPO is ₹171.00 per share.
| Nephro Care IPO | Petro Carbon IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹85.00 per share | ₹162.00 per share |
| Issue Price (Upper) | ₹90.00 per share | ₹171.00 per share |
| Issue Price (Final) | ₹90.00 per share | ₹171.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 1600 shares | 800 shares |
| Fresh Issue Size | 43,53,600 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹39.18 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 61,87,200 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹105.80 Cr |
| Issue Size Total | 43,53,600 shares | 61,87,200 shares |
| Issue Size Total (Amount) | up to ₹39.18 Cr | up to ₹105.80 Cr |
Nephro Care IPO opens on Jun 28, 2024, while Petro Carbon IPO opens on Jun 25, 2024. The closing date of Nephro Care IPO and Petro Carbon IPO is Jul 02, 2024, and Jun 27, 2024, respectively.
| Nephro Care IPO | Petro Carbon IPO | |
|---|---|---|
| Anchor Bid Date | Jun 27, 2024 | Jun 24, 2024 |
| Issue Open | Jun 28, 2024 | Jun 25, 2024 |
| Issue Close | Jul 02, 2024 | Jun 27, 2024 |
| Basis Of Allotment (Tentative) | Jul 03, 2024 | Jun 28, 2024 |
| Initiation of Refunds (Tentative) | Jul 04, 2024 | Jul 01, 2024 |
| Credit of Share (Tentative) | Jul 04, 2024 | Jul 01, 2024 |
| Listing date (Tentative) | Jul 05, 2024 | Jul 02, 2024 |
| Anchor Lockin End date 1 | Aug 02, 2024 | Jul 28, 2024 |
| Anchor Lockin End date 2 | Oct 01, 2024 | Sep 26, 2024 |
Nephro Care IPO P/E ratio is 55.15, as compared to Petro Carbon IPO P/E ratio of 66.02.
| Nephro Care IPO | Petro Carbon IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated Standalone)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 85.02 | 100.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 61.39 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 55.15 | 66.02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹148.38 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 41.57% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 36.56% | 60.36% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.54 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹1.63 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 24.42% | 66.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Nephro Care IPO Retail Individual Investors (RII) are offered 14,44,800 shares while in Petro Carbon IPO retail investors are offered 14,44,800 shares. Qualified Institutional Buyers (QIB) are offered 8,25,600 shares in Nephro Care IPO and 12,36,800 shares in Petro Carbon IPO.
| Nephro Care IPO | Petro Carbon IPO | |
|---|---|---|
| Anchor Investor Reservation | 12,38,400 shares | 18,55,200 shares |
| Market Maker Reservation | 2,30,400 shares | 4,30,400 shares |
| QIB | 8,25,600 shares | 12,36,800 shares |
| NII | 6,19,200 shares | 9,28,800 shares |
| RII | 14,44,800 shares | 21,66,400 shares |
| Employee | 2,25,600 shares | |
| Others | ||
| Total | 43,53,600 shares | 61,87,200 shares |
Nephro Care IPO subscribed 715.78x in total, whereas Petro Carbon IPO subscribed 92.01x.
| Nephro Care IPO | Petro Carbon IPO | |
|---|---|---|
| QIB (times) | 245.14x | 94.49x |
| NII (times) | 1,787.19x | 129.91x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 634.12x | 74.34x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 715.78x | 92.01x |
